Benha University Organized Awareness Seminar on the National Plasma Derivatives Project for Faculty of Arts Students

The Community Service and Environmental Development Sector at Benha University, in collaboration with Grifols Egypt, organized an awareness seminar at the Faculty of Arts titled "The National Plasma Derivatives Project." This initiative is part of the university's efforts to promote health awareness and highlight the importance of plasma donation and its role in supporting the healthcare system and providing essential life-saving medications for patients.
The seminar was held under the auspices of:
• Prof. Nasser El-Gizawy, President of Benha University
• Prof. Taha Ashour, Vice President for Community Service and Environmental Development
• Prof. Amjad Hegazy, Dean of the Faculty of Arts
• Prof. Sherine El-Shoury, Vice Dean for Community Service and Environmental Development.
The seminar featured the presence of:
Prof. Samah Shalaby, Director of the Benha Plasma Donation Center,
coordination by:
Ms. Rania Moataz, Assistant Secretary-General for Community Service.
The discussion focused on the National Plasma Derivatives Project, its objectives, and the importance of plasma donation as a key aspect of supporting the biopharmaceutical industry. It emphasized the state's ability to provide the necessary medical products to treat various diseases, as well as clarifying the differences between blood donation and plasma donation, and addressing questions related to donation procedures and medical regulations.
Prof. Samah Shalaby highlighted the importance of plasma as a source of many proteins and antibodies used in the production of life-saving biopharmaceuticals, explaining the role of plasma derivatives in treating several medical conditions, including certain liver diseases, burns, severe bleeding, immunodeficiency cases, and autoimmune diseases, as well as hemophilia patients who require clotting factors.
The seminar also shed light on the objectives of the National Plasma Derivatives Project, which aims to achieve self-sufficiency in life-saving medications derived from plasma by establishing approximately 20 plasma donation centers across the country, alongside creating a specialized facility for manufacturing, purifying, and packaging, as well as testing laboratories and logistics storage in the New Administrative Capital.